Precision Cell Systems
PrivateLast Round
Corporate Funding
Sep 17, 2025
Momentum Score
50 /100
Company Overview
Precision Cell Systems is a biotechnology company that develops automated cell processing and analysis systems for biomedical research and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precision Cell Systems Comps
Public and private peers based on sector, stage, and business model.
Precision Cell Systems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 17, 2025 |
Key People
Founding team and executive leadership
Precision Cell Systems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BroadOak Capital Partners | Corporate Funding |
| Tramway Venture Partners | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2026
Grew 29% QoQ from 14 to 18 employees.
- Dec 23, 2025
Grew 80% QoQ from 10 to 18 employees.
Precision Cell Systems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Precision Cell Systems's valuation, stock price, and market status.
